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Abstract
Background: Retinoblastoma is caused by loss of the Rb protein in early retinal cells. Although
numerous Rb functions have been identified, Rb effects that specifically relate to the suppression
of retinoblastoma have not been defined.
Results: In this study, we examined the effects of restoring Rb to Y79 retinoblastoma cells, using
novel retroviral and lentiviral vectors that co-express green fluorescent protein (GFP). The
lentiviral vector permitted transduction with sufficient efficiency to perform biochemical analyses.
Wild type Rb (RbWT) and to a lesser extent the low penetrance mutant Rb661W induced a G0/G1
arrest associated with induction of p27KIP1 and repression of cyclin E1 and cyclin E2. Microarray
analyses revealed that in addition to down-regulating E2F-responsive genes, Rb repressed
expression of Brn-2 (POU3F2), which is implicated as an important transcriptional regulator in
retinal progenitor cells and other neuroendocrine cell types. The repression of Brn-2 was a specific
Rb effect, as ectopic p27 induced a G0/G1 block, but enhanced, rather than repressed, Brn-2
expression.
Conclusion: In addition to Rb effects that occur in many cell types, Rb regulates a gene that
selectively governs the behavior of late retinal progenitors and related cells.
Background
Retinoblastomas form due to the inactivation of the RB1
gene together with other genetic changes [1]. Whereas RB1
is also inactivated in other tumors, the cells that give rise
to retinoblastoma are exceptionally sensitive to Rb loss.
Individuals with bilateral retinoblastoma (and presumed
germ line RB1 mutations) develop an average of five retin-
oblastoma foci, generally within their first 2 years [2,3],
but have only ~1% per year likelihood of developing all
other tumor types [4]. Moreover, retinoblastoma is largely
a human-specific disease. Tumors with histopathological
features of retinoblastoma, including photoreceptor but
not amacrine differentiation, have been reported for only
two individual animals [5,6] and appear not to form in
response to the loss of Rb family proteins in mice [7-10].
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Rb has numerous functions that might mediate the sup-
pression of retinoblastoma [11]. Studies in non-retinal
cells have shown that Rb can inhibit cell cycle progression
through regulation of E2F1 and p27Kip1 [12-14], and may
induce a senescence-like response through E2F-depend-
ent or E2F-independent mechanisms [15-17]. In addition,
Rb promotes differentiation through interactions with
several widely expressed proteins [18,19], and may both
promote differentiation and suppress tumorigenesis by
inhibiting Ras [20]. Besides these general effects, Rb pro-
motes osteogenic, adipogenic, thyroid, and melanocytic
differentiation through interactions that are specific to the
relevant cell types [21-26]. Thus, to understand how Rb
suppresses retinoblastoma, it may be necessary to identify
the cell type-specific functions of Rb in the cells that give
rise to retinoblastoma tumors.
At present, the cell type that gives rise to retinoblastoma
has not been identified. It was proposed that retinoblast-
omas arise from a primitive neuroectodermal cell [27],
such as a retinal progenitor cell (RPC) or a transition cell
that fails to arrest in Rb's absence during early differentia-
tion [28]. More recent evidence suggests a possible origin
from post-mitotic cone precursors [29]. However, defin-
ing Rb's tumor suppressor role in any of these cell types is
problematic, as human retinal cells are poorly suited to
growth and manipulation in vitro, and as Rb's tumor sup-
pressor role may not be replicated in vivo, in mouse mod-
els. As an alternative to working with the retinoblastoma
cell of origin, insight into Rb's role may be gained by
examining the effects of restoring Rb to retinoblastoma
cells. While signaling in such cells may differ to some
extent from that in the cell of origin, cell type-specific
retinoblastoma suppressor functions of Rb seem more
likely to be manifested in retinoblastoma cells than in
other available cell types.
The effect of restoring Rb to retinoblastoma cells was first
examined soon after the RB1 gene was cloned. When Rb
was restored using Murine leukemia virus (MLV)-based
retroviral vectors, transduced cells were analyzed after >4
weeks of selection and displayed either modestly dimin-
ished proliferation [30,31] or no obvious change in pro-
liferative rate [32-35]. In contrast, when Rb was restored
by transfer of chromosome 13 (on which RB1 resides),
proliferation was clearly impaired [36]. This suggested
that expression of Rb under its normal regulatory
sequences conferred a stronger antiproliferative effect
than was conferred with MLV-based vectors. However,
chromosome transfer is too inefficient to be used to
define Rb's acute effects, and cannot be used to compare
effects of wild type and mutant Rb proteins.
To define the effects of restoring Rb to retinoblastoma
cells, we developed retroviral and lentiviral vectors that
co-express Rb and enhanced green fluorescent protein
(GFP). As MLV-based retroviral vectors have a propensity
to be silenced by trans-acting factors and DNA methyla-
tion, we used murine stem cell virus (MSCV) and lentivi-
rus vectors that have diminished silencing [37,38]. Use of
the GFP marker permitted the acute effects of Rb to be
observed in the absence of antibiotic selection of trans-
duced cells, and permitted the efficiency of transduction
to be determined prior to biochemical analysis. These
studies demonstrate that several of the Rb effects that have
been observed in other cell types are also manifested in
retinoblastoma cells. In addition, they identify an Rb-reg-
ulated gene that may have a crucial role in retinal cell pro-
liferation.
Results
Restoration of Rb to Y79 cells using the MSCV-GFP 
retroviral vector
In initial experiments, Y79 cells were transduced with the
MSCV-GFP vector or derivatives encoding wild type or
mutant Rb (Figure 1A). In these constructs, Rb was
expressed from the MSCV LTR and GFP from a PGK pro-
moter 3' to the RB1 cDNA. The versions of Rb examined
included the wild type (RbWT), the tumor-derived mutants
RbΔ21 and RbΔ22 [39], a low penetrance mutant (Rb661W)
that retains partial tumor suppressor function but lacks
the ability to regulate E2F1 [40], and a mutant (Rb76t)
with a premature termination codon at amino acid 76
[41].
Viral supernatants were combined with Y79 cells, and
infection monitored by flow cytometry. GFP+ cells were
first detected ~30 h after infection, and peaked at 44 h,
typically in 10–20% of cells. At three days after infection,
western blotting indicated that similar levels of RbWT and
RbΔ21, and slightly higher levels of Rb661W, were produced
(Figure 1B).
Antiproliferative effect of retrovirus-transduced Rb
To determine whether restoring Rb with the MSCV-GFP
vector affected Y79 proliferation, the percentage of GFP+
cells was determined at various times after infection and
normalized to that at 44 h (Figure 1C). The proportion of
GFP+ cells remained constant in cultures transduced with
MSCV-GFP, indicating that transduced and untransduced
cells proliferated at similar rates. In contrast, the propor-
tion of GFP+ cells rapidly declined after transduction with
MSCV-GFP-RbWT, suggesting that proliferation of Rb-
transduced cells was impaired.
Cultures that were transduced with the low penetrance
mutant Rb661W and the tumor-derived mutants RbΔ21 and
RbΔ22 displayed an intermediate decline in GFP+ cells
(Figure 1C and data not shown). To determine whether
this decline required expression of mutant Rb protein,Molecular Cancer 2006, 5:72 http://www.molecular-cancer.com/content/5/1/72
Page 3 of 11
(page number not for citation purposes)
Effect of retroviral Rb transduction on Y79 proliferation Figure 1
Effect of retroviral Rb transduction on Y79 proliferation. A. Structure of the MSCV-GFP retroviral vector and Rb 
derivatives. Rb is expressed from the MSCV LTR, and GFP from a PGK promoter. B. Western analysis of Rb expression 3 days 
after infection. C, D. Prevalence of GFP+ cells after infection with the indicated vectors, relative to that at 44 h after infection, 
displayed as a time course (C) or at day 12 for a separate experiment (D). E. Effect of Rb on cell cycle distribution 84 h after 
infection. F. Effect of Rb on cell size. Cells infected with MSCV-GFP or MSCV-GFP-Rb were identified by GFP fluorescence and 
stained for Rb (left) or measured for forward scatter (FSC) by flow cytometry (right). For C-E, infections were in triplicate, 
data points represent averages, and error bars indicate standard deviation.
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Y79 cells were transduced with MSCV-GFP-Rb76t, which
encodes a truncated and apparently unstable product
[41]. As Rb76t-transduced cultures displayed a similar
decline in GFP+ cells (Figure 1D), the decline observed
with each mutant was likely due to a cis effect of RB1
sequences that resulted in silencing of GFP expression.
To better define the anti-proliferative effect of RbWT, trans-
duced cultures were stained with propidium iodide and
the cell cycle profile of GFP+ cells examined. RbWT, but
not Rb661W or RbΔ21, increased the proportion of GFP+
cells in G0/G1 and reduced the proportions in S and G2/
M (Figure 1E). To our knowledge, this is the first demon-
stration that restoration of Rb alters the cell cycle profile
of retinoblastoma cells. RbWT but none of the Rb mutants
also increased Y79 cell size, as measured by immunocyto-
chemical staining and the flow cytometry forward scatter
parameter (Figure 1F and data not shown).
Culture of Rb-transduced cells selects for low Rb 
expression
In cultures that were transduced with MSCV-GFP-RbWT,
the proportion of GFP+ cells declined for two weeks, but
then remained constant (Figure 1C), indicating that the
remaining GFP+ cells proliferated at the same rate as unin-
fected cells. To determine whether such cells were selected
for decreased Rb, we examined Rb expression in cell pop-
ulations that were equivalent to the GFP+ cells in MSCV-
GFP-Rb transduced cultures, but which expressed puro-
mycin resistance instead of the GFP marker. To do so, Y79
cells were infected with the MSCV-Puro vector or deriva-
tives encoding RbWT or Rb661W, and selected with puromy-
cin. After selection, cells that were transduced with MSCV-
Puro-RbWT, but not those transduced with MSCV-Puro-
Rb661W, had markedly reduced Rb protein (Figure 2A, B)
and RB1 RNA (Figure 2C). Moreover, when the MSCV-
Puro-RbWT-transduced and puromycin-selected cells were
re-infected with MSCV-GFP-RbWT, they displayed a rapid
decline in the proportion of GFP+ cells, similar to that of
the parental Y79 and vector-transduced controls (Figure
2D). This confirmed that Y79 cells that proliferate after Rb
transduction remain sensitive to Rb, but fail to arrest due
to their low Rb levels.
Restoration of Rb using concentrated retroviral and 
lentiviral vectors
We next sought to quantitatively restore Rb to Y79 cells, in
order to define Rb's biochemical effects. As concentrated
MSCV-GFP-Rb preparations infected at most ~40% of Y79
cells, transduced cells were further enriched by FACS, to
yield populations that were ≥ 97% GFP+. As a second
approach, we developed a lentiviral vector to express Rb
and GFP, termed Bidirectional-EF1α-GFP (BE-GFP, Figure
3A). A bidirectional promoter was used to tightly link Rb
and GFP expression, and thus minimize production of
GFP+ cells that have little or no Rb. Concentrated BE-GFP
vector and Rb derivatives were generally of sufficient titer
to transduce >94% of Y79 cells (Figure 3B). This permit-
ted analysis of Rb effects without further cell isolation.
Antiproliferative effect of lentivirus-transduced RbWT and 
Rb661W
At 60 h after lentiviral transduction, RbWT induced an
accumulation in G0/G1 similar to that induced with ret-
roviral transduction (Figure 3C). Lentiviral transduction
of Rb661W  also induced an accumulation in G0/G1,
though to a lesser extent than RbWT. The ability of Rb661W
to elicit a cell cycle block after lentiviral but not retroviral
transduction was most likely due to higher levels of
Rb661W obtained with the EF1α promoter and a higher
multiplicity of infection.
RbWT and Rb661W were previously found to inhibit oste-
osarcoma cell proliferation by inducing a post-transcrip-
tional increase in p27KIP1 [13,14]. Similarly, RbWT and
Rb661W induced p27 in Y79 cells, at levels that were in pro-
portion to Rb protein expression (Figure 3D). To deter-
mine whether p27 might mediate the Rb-induced
proliferative arrest, we compared the effects of ectopic Rb
and ectopic p27, using the same lentiviral vector to
express each protein. Lentiviral p27 transduction resulted
in higher p27 levels, but caused less of an accumulation in
G0/G1, as compared to lentiviral Rb (Figure 4). This
implies that p27 does not fully mediate the Rb-induced
G0/G1 arrest.
Effect of Rb on gene expression
Rb is thought to inhibit proliferation, in part, by repress-
ing E2F-regulated cell cycle genes and promoting expres-
sion of cell type-specific differentiation genes. Thus, we
performed a microarray analysis to assess Rb's effects on
E2F-responsive genes and to identify additional Rb-regu-
lated genes in retinoblastoma cells. RNA was obtained
from FACS-purified GFP+ Y79 cells at 60 h after transduc-
tion with MSCV-GFP or MSCV-GFP-RbWT, and analyzed
by Affymetrix GeneChip. Among well-described E2F-
responsive genes, CDC2,CDK2, cyclin E2, polo-like kinase
(PLK), and p107 (RBL1) were scored as more than 2-fold
repressed, whereas others had comparatively little change
(Table 1). Of these, cyclin E2 and p107 are among the
small subset of E2F-responsive genes that typically require
Rb for normal regulation [11,42-44]. Rb had little effect
on cyclin E1, despite that Rb is required for normal cyclin
E1 regulation in other cell types [44,45].
We further examined the gene expression effects of Rb and
Rb mutants at 60 h after transduction with the BE-GFP
lentiviral vector. In quantitative reverse transcription
(qRT)-PCR analyses, BE-GFP-RbWT diminished cyclin E2
expression by ~90% and decreased cyclin E1 by ~50%,Molecular Cancer 2006, 5:72 http://www.molecular-cancer.com/content/5/1/72
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whereas RbΔ21 and Rb76t derivatives had little or no effect
(Figure 5A). The greater effect of RbWT on cyclin E expres-
sion after lentiviral transduction and qRT-PCR analysis,
compared to retroviral transduction and microarray anal-
ysis, may be due to the higher Rb levels expressed from the
BE-GFP vector as well as methodological differences. BE-
GFP-Rb661W also down regulated cyclin E1 and cyclin E2 by
~50%. The RbWT and Rb661W effects appeared to be spe-
cific, as Rb did not repress the control gene, HSP70A1B.
We next sought to identify additional Rb-regulated genes.
One of the most strongly down-regulated genes in the
microarray analysis was Brn-2 (POU3F2), with a ~20-fold
reduction in signal (Table 1). This effect was confirmed
with qRT-PCR analysis of lentivirus-transduced cells, in
which RbWT repressed Brn-2 by ~90% (Figure 5A). Moreo-
ver, Rb661W down-regulated Brn-2 by 50%, while RbΔ21
and Rb76t had no effect. Rb's regulation of Brn-2 was of
interest because Brn-2  functions as an oncogene in
melanoma cells and is implicated in the control of Chx10
and other genes that are expressed in RPCs [46,47]. To
determine whether this effect indirectly resulted from Rb-
induced cell cycle arrest or p27 expression, we examined
Brn-2  expression after p27 transduction. Ectopic p27
increased the proportion of cells in G0/G1 (Figure 4B),
but induced rather than diminished Brn-2 expression (Fig-
ure 5B). This implies that Rb does not repress Brn-2
through its induction of p27, nor by inducing a G0/G1
arrest.
In summary, Rb not only down regulated E2F-responsive
genes, which are thought to have general, cell type-inde-
pendent functions. Rb also down regulated Brn-2, which
is particularly important to the regulation of gene expres-
sion in RPCs.
Discussion
Retinoblastoma has long served as a paradigm for cancers
that develop due to the loss of a tumor suppressor protein
[48]. However, despite that the Rb tumor suppressor was
identified 20 years ago, the means by which Rb suppresses
this tumor have not been established. In the current study,
we examined the effect of restoring Rb to retinoblastoma
cells. Our rationale was that Rb might perform functions
in retinoblastoma cells that it does not display in other
available cell types, and which may relate to Rb's role in
the retinoblastoma cell of origin. As the retinoblastoma
cell of origin has not been identified, and cell types that
are candidates for the cell of origin are not easily manipu-
lated, retinoblastoma cells may serve as the best available
setting in which to detect Rb functions that specifically
relate to the suppression of this tumor.
Earlier attempts to define Rb's effects in retinoblastoma
cells may have been hampered by an inability to effi-
Long-term culture of Rb-transduced cells selects for low Rb  expression Figure 2
Long-term culture of Rb-transduced cells selects for 
low Rb expression. A. Rb expression in Y79 cells 3 days 
after transduction with MSCV-GFP and Rb derivatives (lanes 
1–3), or in puromycin resistant Y79 cells 26 days after trans-
duction with MSCV-Puro and Rb derivatives (lanes 4–6). 
Lysates from infected cultures were combined with mock-
infected cell lysates to normalize the proportion of GFP+ 
cells. B. Rb expression after transduction with the indicated 
MSCV-Puro viruses and puromycin selection, at 19 days 
(lanes 1, 3, and 5) and 26 days (lanes 2, 4, and 6) after infec-
tion. For A and B, actin expression is displayed as a loading 
control. C. RT-PCR analysis of RB1 and GAPDH mRNA in 
puromycin resistant cells after infection with the indicated 
viruses, with PCR for 22, 26, and 30 cycles. D. Prevalence of 
GFP+ cells at 12 days relative to that at 44 h after infection of 
Y79 cells, or after infection of puromycin-selected Y79 deriv-
atives that were earlier infected with MSCV-Puro or MSCV-
Puro-Rb.
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Lentiviral transduction of Y79 with BE-GFP-Rb Figure 3
Lentiviral transduction of Y79 with BE-GFP-Rb. A. Structure of BE-GFP-RbWT. Rb and GFP are expressed from a bidi-
rectional promoter consisting of EF1α enhancer + promoter (light blue) and a minimal CMV promoter (dark blue) that requires 
a heterologous enhancer for activity [56]. B. Flow cytometric analysis of GFP expression in transduced cultures at 56 h after 
infection. Numbers indicate the percent GFP+ cells. C. Y79 cell cycle profiles 60 h after mock infection or transduction with 
the indicated BE-GFP viruses. D. Western analysis of Rb, p27, and α-actin 60 h after mock infection (lane 1) or infection with 
the indicated BE-GFP viruses (lanes 2–6).
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ciently express Rb and thus examine its acute effects. The
current study surmounted this obstacle by marking the Rb
expression vectors with GFP. This approach revealed that
Rb inhibited proliferation, induced a G0/G1 arrest, and
increased cell size, similar to Rb's effects in other cell
types. Moreover, the studies showed that Rb's anti-prolif-
erative effect was masked when analyzed several weeks
after infection, due to the outgrowth of cells that had low
Rb levels. This implies that prior studies that failed to
demonstrate an antiproliferative effect of Rb after a selec-
tion period may have analyzed cells that had ineffective
levels or Rb expression. The firm demonstration that Rb
inhibits retinoblastoma proliferation validates efforts to
restore Rb function as a therapeutic approach [49]. How-
ever, our results also revealed that a threshold level of Rb
was required to inhibit Y79 proliferation in vitro. Whether
a similar Rb level is needed to inhibit growth of retino-
blastoma tumors in vivo remains to be established.
The Rb-induced G0/G1 arrest was associated with
increased expression of p27 and decreased expression of
E2F-responsive genes, as previously observed in other cell
types. In osteosarcoma cells, the induction of p27 pre-
ceded the decline in proteins encoded by E2F-responsive
genes, and was needed for Rb to rapidly induce a cell cycle
block [14]. To date, it has not been possible to determine
whether the up-regulation of p27 is required for Rb to
arrest Y79 cells, as p27 knockdown did not preclude the
induction of p27 by Rb (data not shown). However, our
finding that Rb was more effective than p27 in inducing a
G0/G1 arrest suggests that Rb inhibits Y79 proliferation at
least in part through a p27-independent process, such as
by repressing cyclin E2 and other E2F-responsive genes.
Notably, the low penetrance mutant Rb661W also induced
a G0/G1 block, p27 expression, and down-regulation of
cyclin E, albeit to a lesser extent than RbWT. This is consist-
ent with the ability of Rb661W to induce a proliferative
arrest via p27 in osteosarcoma cells [14], and with evi-
dence that Rb661W  may regulate E2F-responsive genes
through an interaction with E2F2 [50].
In addition to Rb's effect on E2F-regulated genes, Rb
strongly repressed Brn-2. This effect is notable in light of
evidence that Brn-2 is highly expressed small cell lung can-
cers [51], which like retinoblastomas generally lack Rb
[39], and in light of evidence that Brn-2 functions as an
oncogene in melanoma cells [46,52]. Thus, the finding
that Rb represses Brn-2 raises the possibility that deregula-
tion of Brn-2 contributes to retinoblastoma tumorigene-
sis.
During retinal development, Brn-2 is expressed in inter-
mediate and late RPCs as well as in certain post-mitotic
cells [47]. Brn-2 may have a widespread transcriptional
role in RPCs, as it binds the promoters of the characteristic
RPC genes, Chx10 and Nestin, and may bind related pro-
moter sites in Cyclin D1 and Pax6 [47]. In cortical devel-
opment, Brn-2 is similarly expressed in late progenitors,
and is required in combination with Brn-1 for late progen-
itor cell proliferation [53]. These findings suggest that Brn-
2 may promote the expression of genes that maintain late
progenitor cell proliferation, and that deregulation of Brn-
2 in response to Rb loss may elicit aberrant expression of
such genes, increased proliferation, and retinoblastoma
tumorigenesis. Alternatively, as Rb is also expressed in
post-mitotic retinal cells [29], Rb-mediated repression of
Brn-2 may contribute to the suppression of retinoblast-
oma in post-mitotic retinal precursors.
Comparison of Rb and p27 cell cycle effect Figure 4
Comparison of Rb and p27 cell cycle effect. A. Y79 
cells were mock infected (lane 1) or infected with BE-GFP, 
BE-GFP-Rb, or BE-GFP-p27 (lanes 2–4); and examined by 
western blotting for p27 expression, and for actin expression 
as a loading control. B. Infected cells were stained with pro-
pidium iodide and examined for cell cycle position.
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Conclusion
Rb was expressed in Y79 cells using novel retroviral and
lentiviral vectors. Rb induced a G0/G1 arrest, expression
of p27KIP1, and repression of E2F-responsive genes such as
cyclin E1 and cyclin E2, similar to Rb's effects in other cell
types. In addition, Rb decreased expression of Brn-2,
Table 1: Gene expression effects of retroviral Rb transduction
Gene Probe Set Accession # Fold Change
Controls
GAPDH M33197_M_at 0.92
M33197_3_at 0.91
M33197_5_at 0.82
β-actin 200801_x_at 1.07
E2F-responsive
CDC2 203214_x_at 0.53
210559_s_at 0.63
203213_at 0.70
231534_at 0.43*
CDC25A 204695_at 0.60
1555772_a_at 0.76
CDC25B 201853_s_at 0.93
CDC25C 205167_s_at 0.89
CDK2 204252_at 0.38*
Cyclin A2 203418_at 0.61
Cyclin B1 214710_s_at 0.74
228729_at 0.76
Cyclin B2 202705_at 0.76
Cyclin E1 213523_at 0.92
Cyclin E2 211814_s_at 0.37*
205034_at 0.61
E2F1 204947_at 0.92
2028_s_at 0.67
E2F2 228361_at 0.56
E2F3 203692_s_at 1.31
203693_s_at 1.02
EMI1 (FBXO5) 218875_s_at 0.66
234863_x_at 0.55
Geminin 218350_s_at 0.63
HPRT 202854_at 0.65
N-myc 209757_s_at 1.06
PCNA 201202_at 0.90
PLK 214372_x_at 0.80
202240_at 0.42*
RbL1 (p107) 1555004_a_at 0.44*
Ribonuc. Reductase M1 201477_s_at 0.65
201476_s_at 0.50
Ribonuc. Reductase M2 209773_s_at 0.74
SKP2 210567_s_at 1.16
203626_s_at 0.77
Thymidlyate Synthase 202589_at 0.74
1554696_s_at 0.57
Thymidine Kinase 243103_at 0.98
1554408_a_at 0.82
202338_at 0.59
Novel
Brn-2 (POU3F2) 207084_at 0.05**
Affymetrix U133 Plus 2.0 microarrays were hybridized with probes from vector- and Rb-transduced cells and analyzed with Affymetrix Microarray 
Suite software. The indicated probe sets were flagged as "Present" in vector transduced samples, and showed the indicated fold change in signal for 
Rb-transduced versus vector-transduced samples. Asterisks indicate probe sets with fold change less than 0.5. The double asterisk indicates one of 
the most strongly down-regulated genes in the microarray analysis.Molecular Cancer 2006, 5:72 http://www.molecular-cancer.com/content/5/1/72
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which selectively regulates gene expression in RPCs and
related cells. Thus, in addition to Rb's cell type-independ-
ent effects, Rb regulates genes that control transcription in
the developing retina.
Methods
DNA constructs
MSCV-GFP was constructed by replacing the HindIII-ClaI
fragment of MSCV-Puro (Clontech) with a HindIII-NotI
fragment from pEGFP-N2 (Clontech). To produce MSCV-
GFP derivatives, BamHI-StuI fragments from pSVE-
hRBWT, pSVE-hRBΔ22  [54], pSVE-hRB661W  [DC unpub-
lished data, 40], and pSVE-Rb76t [41] were inserted to the
BglII-HpaI sites of MSCV-GFP. Similarly, MSCV-Puro-
RbWT was produced by inserting the pSVE-hRBWT BamHI-
StuI fragment in the MSCV-Puro BglII-HpaI site. MSCV-
GFP-RbΔ21 was produced by replacing an MluI-MfeI frag-
ment of MSCV-GFP-RbWT  with the corresponding
sequence from pGST-RbΔ21 [55].
BE-GFP was produced by replacing the EcoRV-SalI frag-
ment of MA1, containing a PGK-TrkA cassette [56], with
the polylinker sequence 5'-GGGGCTAGCTCTA-
GAACGCGTCGTACGACTCGAGTGTTTAAAC-3', and
inserting an EF1αpromoter fragment between the
polylinker NheI-XbaI sites. RbWT, Rb661W, RbΔ21, and Rb76t
cDNAs were transferred as BssHII-BsrGI fragments from
MSCV-GFP to the BE-GFP MluI-BsiWI sites. p27KIP1 cDNA
was transferred as a KpnI-XbaI fragment from cDNA3-p27
(kindly provided by A. Koff) to the corresponding BE-GFP
sites.
Cell growth, virus production, infection, and Y79 sublines
Y79 cells were obtained from the ATCC and cultured in
RPMI 1640, 10% fetal calf serum (FCS), penicillin, strep-
tomycin, and L-glutamine, in a humidified 5% CO2 incu-
bator. Retroviral supernatants used for direct infections
were made by CaPO4-mediated co-transfection of Bing
producer cells with the indicated MSCV-GFP constructs
and pCL-Ampho [57]. Concentrated retrovirus was pro-
duced by CaPO4-mediated co-transfection of GP2 cells
(Clontech) with MSCV-GFP constructs and pVSVg [58].
Lentivirus was produced using Lipofectamine 2000 (InV-
itrogen) to co-transfect 293T cells with the viral vector,
pVSVg, and pΔ8.91 DNAs [59]. Cell supernatants were
passed through 0.45 μm cellulose acetate filters 48 h after
transfection. Virus was concentrated by centrifugation at
25,000 rpm for 90 min in a SW28 rotor, and suspended in
50 mM Tris, pH 7.8, 130 mM NaCl, and 1 mM EDTA. For
infections, Y79 cells were plated at 2 × 106 cells per ml and
combined with an equal volume of producer cell superna-
tants, or with up to 0.5 volume of concentrated virus, at 6
μg/ml polybrene. As MSCV-GFP titers were ~10-fold
higher than for Rb derivatives, MSCV-GFP supernatants
were diluted 10-fold prior to infection.
Cells transduced with MSCV-Puro or Rb derivatives were
selected with 1.5 μg/ml puromycin for 11 days, and re-
infected with MSCV-GFP and Rb derivatives 20 days after
the initial infection.
Analysis of infected cells
GFP expression and forward scatter were determined
using a Becton-Dickenson FACSCaliber and CellQuest
Software. Cell cycle positions of retrovirus-transduced
cells were determined by fixing in 0.75% paraformalde-
hyde (PFA) for 30 min at 22°C, washing in PBS + 3% FCS,
fixing in 70% ethanol at -20°C, staining in 0.05 mg/ml
propidium iodide, 0.6% Nonidet-P40 in PBS, and 1 mg/
ml RNAse A, and gating on diploid GFP+ cells. Cell cycle
Gene expression effects of Rb and p27 Figure 5
Gene expression effects of Rb and p27. cDNA was pre-
pared from cells at 60 h after infection with the BE-GFP vec-
tor and A) the indicated Rb derivatives, or B) either RbWT 
or p27 derivatives. The cDNA was subjected to qRT-PCR 
for the indicated genes. Expression levels were normalized to 
β-actin and are displayed relative to that of vector-trans-
duced samples. Values indicate averages of duplicate analyses 
and error bars indicate standard deviation.
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positions of lentivirus-transduced cells were determined
as above but without PFA fixation or GFP gating.
For immunofluorescent detection of Rb, Y79 cells were
attached to poly-L-lysine coated slides, fixed in 4% PFA
for 10 min and stained with anti-Rb antibody G3-245
(1:200, Becton-Dickenson) and Cy3-conjugated donkey
anti-mouse. For immunoblotting, lysates were separated
and immunoblotted to Hybond-P and probed using ECL-
Advance (Amersham), with mouse anti-Rb G3-245
(1:1,200), rabbit anti-p27 (1:150, SantaCruz sc-528), and
rabbit anti-α-actin (1:1,000, Sigma A2066). To compare
Rb expression after retroviral infection, infected cell
lysates were combined with mock-infected cell lysates to
normalize for the proportion of GFP+ cells.
RB1  cDNA expressed following retroviral transduction
was detected by RT-PCR with forward primer 5'-GCTT-
GAGTTTGAAGAAACAGAAGAACC and reverse primer 5'-
CTTTAGCTAATAAAAATGTGATCCAAGAAACTT, and
with a GAPDH control.
Gene expression analysis
RNA was prepared 60 h after lentivirus infection or after
retrovirus infection followed by FACS enrichment to
>97% GFP+ cells. In the latter case, cells were suspended
in Buffer RLT (Qiagen) within 10 min after sorting. RNA
was prepared using RNeasy (Qiagen) including on-col-
umn DNAse digestion, and RNA quality confirmed by
Agilent BioAnalyzer. For microarray analysis, 10 ng of
each RNA was used to prepare probes with the Ovation
Biotin Amplification System (Novogen), and probing
Affymetrix U133 Plus 2.0 GeneChip. For real-time quan-
titative PCR (RT-qPCR), oligo dT-primed cDNA was pre-
pared from 750 ng RNA and ImProm-II reverse
transcriptase (Promega), and cDNA transcribed from 5 ng
of RNA subjected to RT-qPCR using iTaq SYBR Green
Supermix (Bio-Rad), and normalized to β-actin RNA
measured by Taqman (Applied Biosystems). PCR primers
were for cyclin E1 (forward 5'-CGTGCGTTTGCTTTTA-
CAGA, reverse 5'-AGCACCTTCCATAGCAGCAT); cyclin
E2 (forward 5'-CCTCCATTGTGAGATAAGGACA, reverse
5'-GCCTATGTACAGCAAGTTTTCA);  Brn-2  (forward 5'-
CAGAGAGATGGCAAGCACTG, reverse 5'-TCAG-
GAAGCTGCATTTTGTG); and HSP70A1B  (forward 5'-
CCGAGAAGGACGAGTTTGAG, reverse 5'-GCAG-
CAAAGTCCTTGAGTCC).
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